The Board of Directors of Theradiag SA has decided to appoint Mr. Simon Davière as Chief Executive Officer to replace Mr. Bertrand de Castelnau, who has also resigned, as of March 1st, 2023. Simon Davière, 39 years old, holds an engineering degree in Biological Engineering from the University of Technology of Compiègne and a Master's degree in Biotechnology from the University of Technology of Lille. He has a solid professional experience of nearly 15 years in the in vitro diagnostics industry and personalised medicine, particularly in the field of chronic inflammatory diseases.

He started his career at EUROIMMUN before joining Theradiag where he held several managerial positions in marketing and medico-marketing before taking over the management of the Theranostic Business Unit.